Further, the expression of this enzyme is elevated in cancer cells that are resistant to clinical anticancer drugs such as ethoxyquin, doxorubicin, and lipopolysaccharide (12–14), suggesting a potential association between the AKR1B10 expression and resistance to chemotherapy. This evidence concerns the gene AKR1B10 and cancer.